Lung cancer
Lung cancer
“My 2021 healthcare resolution": 7 Johnson & Johnson leaders share their goals for advancing healthcare and health equity
A potential COVID-19 vaccine. Passionate efforts toward achieving racial and social justice. Smarter, more sustainable product packaging. These are just a few of the resolutions company change makers are aiming to bring to light this year—and they’re already hard at work on them.
She oversees one of the world’s largest healthcare businesses: 7 questions for Ashley McEvoy in the time of COVID-19
Johnson & Johnson develops consumer products, medical devices and pharmaceuticals—and McEvoy is at the helm of its global Medical Devices Companies. She shares how she has navigated the pandemic, grown professionally and personally as a result, and helped impact the lives of millions during this unique moment in history.
An expert explains the latest good—yes, good!—news about lung cancer
A new report from the American Cancer Society sheds light on declining death rates from cancer—especially lung cancer. We asked an expert on the disease to break down the data, and share what’s to come in better detecting and preventing it.
I have a vision for helping advance healthcare: Meet 6 leaders working on inspiring innovations in 2020
From robotics solutions for orthopedic surgery to the potential to bring new hope to patients living with multiple myeloma through CAR-T, these are just some of the cutting-edge projects that these visionaries think could potentially help propel healthcare forward around the globe.
New study shows researchers may be one step closer to intercepting lung cancer earlier
A team of scientists, including those from Janssen and the Lung Cancer Initiative at Johnson & Johnson, found that biomarkers related to the immune system may be able to aid doctors in identifying high-risk lung cancer patients—and treating them—at the earliest stage of the disease.
He helped pioneer robotic surgery. Now he wants to reinvent lung cancer care
Frederic Moll, M.D., has been called “the father of robotic surgery” for good reason—his inventions have helped pave the way for improved surgical procedures for decades. His new challenge: an innovation that has the potential to diagnose and treat disease at the same time.
Lung cancer: What you need to know about your risk factor—even if you’ve never smoked
Some 20% of people diagnosed with the disease haven’t touched a cigarette. For Healthy Lung Month, scientists who’ve dedicated their research to defeating lung cancer discuss why early detection is so key—and what you can do to protect yourself.
New Year, new vision: Meet a scientist who spends his days studying the microscopic world of the microbiome
Trillions of beneficial bacteria live in and all around us. What if we could use them to our advantage, to do everything from prevent diabetes to reduce inflammation? Dirk Gevers, Ph.D., Global Head of the Janssen Human Microbiome Institute, shares how his team is already well on that research path.
20 inspiring stories of progress and hope for the future of healthcare
From breakthrough work to eradicate some of the world’s deadliest diseases to advancements in cutting-edge health technology, see just some of the ways Johnson & Johnson is working to help change the trajectory of health for humanity.
How Johnson & Johnson is pioneering in the fight against the world’s #1 cancer killer
The doctor overseeing the company’s new Lung Cancer Initiative reveals why it’s uniquely qualified to work on thwarting the disease—and why he’s uniquely qualified to oversee its efforts.